SOPHiA GENETICS
SOPH
31 hedge funds and large institutions have $82.1M invested in SOPHiA GENETICS in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 3 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
0.6% more ownership
Funds ownership: 26.81% → 27.41% (+0.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
5% less capital invested
Capital invested by funds: $86.3M → $82.1M (-$4.23M)
3% less funds holding
Funds holding: 32 → 31 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$10.8M |
| 2 |
ACM
AKRE Capital Management
Middleburg,
Virginia
|
+$7.96M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$1.76M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$207K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.65M |
| 2 |
BlackRock
New York
|
-$1.43M |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.03M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$302K |
| 5 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$63.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $3.21K | – | – | – |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | +$73 | +15 | +3% |
|
|
PS
28
Principal Securities
Des Moines,
Iowa
| $431 | – | – | – |
|
29
Russell Investments Group
London,
United Kingdom
| $238 | – | – | – |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $160 | +$171 | +35 | New |
|
31
Citigroup
New York
| $69 | +$73 | +15 | New |
|
|
PHP
32
Parkman Healthcare Partners
Stamford,
Connecticut
| – | -$1.03M | -209,896 | Closed |
|
|
SSA
33
Schonfeld Strategic Advisors
New York
| – | -$302K | -61,200 | Closed |
|
|
NA
34
Nordwand Advisors
Radnor,
Pennsylvania
| – | -$2.46K | -500 | Closed |
|
SOPH Hedge Fund Activity: Q2 2024 in Review
31 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q2 2024, worth a combined $82.1M — down 4.9% from $86.3M a quarter earlier.
Fund positioning in SOPH was balanced in Q2 2024: 3 funds opened new positions, 3 closed out, 9 added to existing stakes and 7 trimmed.
The largest buyer was UBS AM, opening a new position worth an estimated $10.8M. The largest seller was Millennium Management, cutting an estimated $5.65M.
- 31 institutional investors held SOPHiA GENETICS (SOPH) as of Q2 2024, down from 32 in Q1 2024.
- Funds reported $82.1M of SOPHiA GENETICS stock for Q2 2024, down 4.9% quarter-over-quarter.
- 3 funds opened new SOPHiA GENETICS positions in Q2 2024 and 3 closed out, a net change of 0 holders.
- The largest SOPHiA GENETICS buyer in Q2 2024 was UBS AM, an estimated $10.8M added.
- The largest SOPHiA GENETICS seller in Q2 2024 was Millennium Management, an estimated $5.65M sold.
Based on aggregated 13F filings for Q2 2024.